Sarcoma Oncology Center (Santa Monica, CA) › P2B-029

P2B-029

A Multicenter, Randomized, Open-Label Phase 2b Study to Investigate the Preliminary Efficacy and Safety of INNO-206 (Doxorubicin-EMCH) Compared to Doxorubicin in Subjects With Metastatic, Locally Advanced, or Unresectable Soft Tissue Sarcoma · Phase II
Sarcoma Oncology Center (Santa Monica, CA) · Dr. Reyes
consented 2012-08-15

completed

AEs

Serious

Dropout signal

–

Adverse events

Grade 1 asthenia with onset in cycle 1 (2012-09-04); assessed as not related to study drug (not related); resolved 2012-09-21.

mild assessed

Grade 2 febrile neutropenia with onset in cycle 1 (2012-08-26); assessed as related to study drug (probable); resolved 2012-09-11; action: drug withdrawn.

moderate assessed

Grade 1 nausea with onset in cycle 1 (2012-08-23); assessed as not related to study drug (not related); resolved 2012-08-27.

mild assessed

Data queries

No data queries. Open queries would appear here for this patient.